IPP Bureau
Samina Hamied of Cipla is the new VP of the IPA for 2021-23
By IPP Bureau - October 04, 2021
Cipla is a leading global pharma company
Max Healthcare to construct two 500-bed hospitals in Gurugram
By IPP Bureau - October 04, 2021
The two plots are located in the heart of Gurugram close to Sectors 53 on the Golf Course Road and Sector 56 just minutes away from the other location
L&T Technology Services (LTTS), collaborates with Intel for Chest rAI solution
By IPP Bureau - October 01, 2021
The AI-infused solution enables radiologists by fast triaging abnormalities in X-ray, annotating and automatic report generation with significantly improved performance
Veeda Clinical Research files DRHP for Rs 831 crore IPO
By IPP Bureau - October 01, 2021
The issue will consist of the issuance of fresh equity shares worth up to Rs 331.60 crore and an offer for sale (OFS) of Rs 500 crore by promoters and existing shareholders
Global Health files DRHP for over Rs 500 crore issue
By IPP Bureau - October 01, 2021
Global Health operates a network of four hospitals under the Medanta brand in Gurugram, Indore, Ranchi and Lucknow. In addition, one hospital is under construction in Patna, and another is planned for development in Noida
NITI Aayog launches report on best practices in district hospitals
By IPP Bureau - October 01, 2021
A total of 707 district hospitals across all states and union territories participated in the performance assessment. The Health Management Information System (HMIS) data for the year 2017–18 has been used as a baseline for this exercise
Jubilant concludes pre-IND meeting of JB1-802 with U.S. FDA
By IPP Bureau - October 01, 2021
The company plans to submit the IND application by the end of 2021
Natco announces launch of 10 mg Everolimus in the US
By IPP Bureau - October 01, 2021
According to industry sales data, the 10mg strength of Afinitor generated annual sales of US $ 392 million during the twelve months ending July 2021
Takeda to collaborate with JCR Pharma to commercialise next-gen Hunter Syndrome therapy
By IPP Bureau - October 01, 2021
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
NASSCOM CoE-IoT announces winners of Healthcare Innovation challenge
By IPP Bureau - October 01, 2021
This one-of-a-kind innovation challenge is aimed at addressing the challenges faced by healthcare providers in digital technology adoption
Merck to acquire Acceleron for US $ 11.5 billion
By IPP Bureau - October 01, 2021
The acquisition complements and strengthens Merck’s cardiovascular pipeline
Merck and Ridgeback’s molnupiravir offer hope to Covid-19 patients
By IPP Bureau - October 01, 2021
If cleared, Merck's drug would be the first pill shown to treat Covid-19, a potentially major advance in efforts to fight the pandemic
Aurobindo Pharma’s subsidiary opens logistics centre in France
By IPP Bureau - September 30, 2021
The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon
WHO new Essential Medicines Lists focus on diabetes and cancer
By IPP Bureau - September 30, 2021
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all
TCS to assist Sweden’s largest pharma retailer Apoteket in its digital transformation
By IPP Bureau - September 30, 2021
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
